In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

41 results for your search

"Belling the Cat" - Practical guide for cardiologists on Incorporating GLP-1RAs into comprehensive cardiovascular risk reduction

Event : ESC Congress 2019

  • Session : Multi-dimensional glucagon-like peptide-1 receptor agonists - Positioning their role in treatment of type 2 diabetes and cardiovascular disease
  • Speaker : M Kosiborod (Kansas,US)
  • Sponsored by Novo Nordisk A/S

All you need to know about functional mitral regurgitation in heart failure patients

Event : ESC Congress 2019

  • Session : Functional mitral regurgitation in heart failure - Time to treat!
  • Speaker : V Delgado (Leiden,NL)
  • Sponsored by Abbott Structural Heart

Audience questions and answers, summary and close

Event : ESC Congress 2019

  • Session : SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes
  • Speaker : TF Luscher (London,GB)
  • Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Beyond real word evidence: learnings from databases and registers

Event : ESC Congress 2019

  • Session : NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice
  • Speaker : J Beyer-Westendorf (Dresden,DE)
  • Sponsored by Bayer AG

Case clinic - Treating the patient who needs more

Event : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : G Montalescot (Paris,FR), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Chair's Welcome

Event : ESC Congress 2019

  • Session : Multi-dimensional glucagon-like peptide-1 receptor agonists - Positioning their role in treatment of type 2 diabetes and cardiovascular disease
  • Speaker : L Ryden (Stockholm,SE)
  • Sponsored by Novo Nordisk A/S

Challenges in the treatment of the elderly atrial fibrillation patient

Event : ESC Congress 2019

  • Session : Anticoagulation in the aging atrial fibrillation population
  • Speaker : R De Caterina (Pisa,IT)
  • Sponsored by Daiichi Sankyo Europe GmBH

Closing remarks

Event : ESC Congress 2019

  • Session : NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice
  • Speaker : R Bauersachs (Darmstadt,DE)
  • Sponsored by Bayer AG

Connecting with the speakers - Questions and answers

Event : ESC Congress 2019

  • Session : Multi-dimensional glucagon-like peptide-1 receptor agonists - Positioning their role in treatment of type 2 diabetes and cardiovascular disease
  • Speaker : L Ryden (Stockholm,SE), S Verma (Toronto,CA), M Kosiborod (Kansas,US)
  • Sponsored by Novo Nordisk A/S

ENTRUST- AF PCI trial

Event : ESC Congress 2019

  • Session : Antithrombotic therapy in atrial fibrillation patients undergoing PCI: where do we stand?
  • Speaker : A Goette (Paderborn,DE)
  • Daiichi Sankyo Europe GmbH

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are